|
Herrero MT, Yuste JE, Cuenca-Bermejo L, Almela P, Arenas-Betancur L, De Pablos V, Gonzalez-Cuello A, Del Bel E, Navarro-Zaragoza J, Fernandez-Villalba E. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biol. 2023 May;13(5):220370. doi: 10.1098/rsob.220370. Epub 2023 May 17. PubMed PMID: 37192671; PubMed Central PMCID: PMC10188238.
AÑO: 2023; IF: 4.5
|
37192671
|
Navarro-Zaragoza J, Martinez-Laorden E, Teruel-Fernandez FJ, Gomez-Murcia V, Canovas A, Milanes MV, Laorden ML, Almela P. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis. Pharmacol Biochem Behav. 2021 Feb;201:173106. doi: 10.1016/j.pbb.2021.173106. Epub 2021 Jan 12. PubMed PMID: 33444599.
AÑO: 2021; IF: 3.697
|
|
Navarro-Zaragoza J, Cuenca-Bermejo L, Almela P, Laorden ML, Herrero MT. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease? Int J Mol Sci. 2021 Mar 16;22(6):3038. doi: 10.3390/ijms22063038. PubMed PMID: 33809767; PubMed Central PMCID: PMC8002365.
AÑO: 2021; IF: 6.208
|
|
Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, Fernandez Villalba E, Gonzalez-Cuello AM, Laorden ML, Herrero MT. Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence. Int J Mol Sci. 2021 Dec 16;22(24):13488. doi: 10.3390/ijms222413488. PubMed PMID: 34948285; PubMed Central PMCID: PMC8705692.
AÑO: 2021; IF: 6.208
|
|
Cuenca-Bermejo L, Almela P, Gallo-Soljancic P, Yuste JE, de Pablos V, Bautista-Hernandez V, Fernandez-Villalba E, Laorden ML, Herrero MT. Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys. Sci Rep. 2021 Oct 6;11(1):19871. doi: 10.1038/s41598-021-99237-5. PubMed PMID: 34615910; PubMed Central PMCID: PMC8494805.
AÑO: 2021; IF: 4.996
|